A carregar...
Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacy
Pulmonary arterial hypertension (PAH) is a progressive disease that causes severe disability and has no cure. Over the past 20 years, a variety of treatment options have evolved for the management of PAH. With an expanded therapeutic armamentarium come more complex decisions regarding treatment opti...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3108715/ https://ncbi.nlm.nih.gov/pubmed/21701627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S6215 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|